Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Melbourne Stem Cell Centre (MSCC) is an Australian-based clinical and research organization specializing in regenerative medicine and mesenchymal stem cell (MSC) therapies. The center focuses on the development and application of autologous adipose-derived MSCs to treat chronic musculoskeletal conditions, particularly osteoarthritis and degenerative disc disease. MSCC distinguishes itself by conducting rigorous, ethics-approved clinical trials to validate the safety and efficacy of its cellular protocols. Their work integrates clinical practice with translational research, aiming to provide non-surgical alternatives for joint and spinal health. By publishing trial results in peer-reviewed journals, the center contributes to the global evidence base for regenerative cellular therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Melbourne Stem Cell Centre.